SOSV

Develops novel drug discovery platform to target epigenetic targets in pediatric brain cancer

Provides continuous hyper-fermentation technology for industrial-scale bio-production

Decodes the dark proteome using an AI-powered novel sequencing and discovery platform to reveal novel cancer targets

Develops non-invasive multi-omic testing platform for skin health and cosmetics using AI and microbiome analysis

Develops non-invasive ultrasound neuromodulation therapies to treat immune-mediated diseases